10.83 USD
↗ 0.16 (1.50%)AT CLOSE (11:59 AM EDT)
PERRIGO COMPANY PLC
PRGONYSE • USD
10.79
↘ 0.04 (0.38%)
POST MARKET (AS OF 07:15 PM EDT)
Post Market
AS OF 07:15 PM EDT
10.79
↘ 0.04 (0.38%)
Market: OPEN
Open?$10.67
High?$10.87
Low?$10.62
Prev. Close?$10.67
Volume?3.0M
Avg. Volume?2.5M
VWAP?$10.74
Rel. Volume?1.19x
Bid / Ask
Bid?$10.67 × 100
Ask?$10.84 × 1.0K
Spread?$0.17
Midpoint?$10.75
Valuation & Ratios
Market Cap?1.5B
Shares Out?138.4M
Float?137.0M
Float %?99.5%
P/E Ratio?N/A
P/B Ratio?0.59
EPS?-$13.14
Dividend?10.74%
Ex-Dividend?N/A
PERRIGO COMPANY PLC (PRGO) trades at $10.79 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, PRGO appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Employees
8.1K
Market Cap
1.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1991-12-16
Address
THE SHARP BUILDING
DUBLIN 2, L2 D02 TY74
Phone: 269-673-8451
DUBLIN 2, L2 D02 TY74
Phone: 269-673-8451
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?1
Momentum?50
Short Sent.?35
Piotroski F-Score?2/9Weak
Altman Z-Score?-0.40Distress
Confidence?63%Moderate
Short InterestHigh
Short % of Float?10.54%High
Short Interest?14.4M
Days to Cover?5.6
Free Float137.0M
Avg Daily Volume2.6M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.80Strong
Quick Ratio?1.64Adequate
Cash Ratio?0.37Low
Debt/Equity?1.45Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.59CHEAP▾
Peers100
S&P97
P/S?0.35CHEAP▾
Peers100
S&P97
P/FCF?13.5CHEAP▾
Peers100
S&P79
EV/EBITDA?7.8CHEAP▾
Peers100
S&P91
EV/Sales?1.14CHEAP▾
Peers100
S&P90
Returns & Efficiency
ROE?-72.7%WEAK▾
S&P3
ROA?-22.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$109.2M
Enterprise Value?$4.8B
Fundamentals ratios updated end of day